Day: March 3, 2019

FDA Approval Expected Monday of Ketamine-derived “Spravato”

      TAKE HOME POINTS: SpravatoTM, a form of ketamine, will be FDA approved on Monday for Treatment Resistant Depression and for Major Depression with suicidality. FDA approval will result in insurance coverage for this form of ketamine, for this purpose, which will make it affordable for millions of suffering patients. Although it is...

MORE

Popular Blog Posts

Coronavirus Anxiety Syndrome
Coronavirus Anxiety Syndrome

FDA Approval Expected Monday of Ketamine-derived “Spravato”

      TAKE HOME POINTS: SpravatoTM, a form of ketamine, will be FDA approved on Monday for Treatment…

LEARN MORE

End The Stigma!

Lady Gaga and Bradley Cooper did a masterful remake of “A Star is Born”, now in theaters. We highly…

LEARN MORE

New Psychology Today article on Ketamine

The current edition of Psychology Today has a (mostly accurate) article about the revolutionary success ketamine has in treating…

LEARN MORE

Dr. Sanjay Gupta on CNN: “Ketamine offers lifeline for people with severe depression, suicidal thoughts”

In this post, a Wisconsin man who had been on the brink of suicide, told CNN’s Sanjay Gupta how…

LEARN MORE

The Resurgence of Psychedelics in Medicine

There has been a flurry of articles in the media recently touting the successful use of psychedelics in medicine.…

LEARN MORE